Miltenyi Biotec is one of NA-ATTC’s partners working closely with some of our manufacturers.  In May 2019 Miltenyi Biotec presented at the World Advanced Therapies & Regenerative Medicine Congress (Terrapinn).  The presentation centred around their CliniMACS Prodigy® device, a closed and automated platform with the capability to manufacture various cell types on a single device and within a single closed process setup.  A video (link below) has since been produced on this next generation automated cell processing, and informs about the overall concept of Miltenyi Biotec’s clinical manufacturing technology, their Cell Factory, and their overall vision behind it.